Method of treating cancer associated with a RAS mutation
US11045467B2 · kind B2 · utility
4Cited by
47References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 1, 2020 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Jun 1, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of treating a cancer characterized by expressing a mutant form of a RAS protein. Some embodiments relate to treatment of cancer by administering Plinabulin to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.